| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 178 |
| 1 | DENOSUMAB | 166 |
| 2 | ERGOCALCIFEROL | 163 |
| 3 | ASPIRIN | 161 |
| 4 | ASPIRIN 81 MG | 154 |
| 5 | ASPIRIN 325 MG | 153 |
| 6 | PREDNISONE | 147 |
| 7 | OMEPRAZOLE | 139 |
| 8 | GABAPENTIN | 129 |
| 9 | ACETAMINOPHEN | 128 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EFGARTIGIMOD ALFA AND HYALURONIDASE (HUMAN RECOMBINANT) | 7 | 0.0144 |
| 1 | HISTAMINE | 2 | 0.0138 |
| 2 | EFGARTIGIMOD ALFA | 34 | 0.0086 |
| 3 | MINERAL OIL, WHITE PETROLATUM | 2 | 0.0069 |
| 4 | CLINDAMYCIN PHOSPHATE | 38 | 0.0069 |
| 5 | NIPOCALIMAB-AAHU | 2 | 0.0063 |
| 6 | PSYLLIUM HUSK | 8 | 0.0059 |
| 7 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 25 | 0.0055 |
| 8 | ERGOCALCIFEROL | 163 | 0.0055 |
| 9 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 15 | 0.0054 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 341 |
| 1 | Corticosteroid [EPC] | 315 |
| 2 | Benzodiazepine [EPC] | 273 |
| 3 | Proton Pump Inhibitor [EPC] | 188 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 167 |
| 5 | RANK Ligand Inhibitor [EPC] | 166 |
| 6 | Provitamin D2 Compound [EPC] | 163 |
| 7 | Complement Inhibitor [EPC] | 160 |
| 8 | Atypical Antipsychotic [EPC] | 159 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 151 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 17 | 0.0137 |
| 1 | Neonatal Fc Receptor Blocker [EPC] | 46 | 0.0105 |
| 2 | Interleukin-5 Antagonist [EPC] | 6 | 0.0087 |
| 3 | Provitamin D2 Compound [EPC] | 163 | 0.0055 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 8 | 0.0039 |
| 5 | Endoglycosidase [EPC] | 7 | 0.0038 |
| 6 | Complement Inhibitor [EPC] | 160 | 0.0028 |
| 7 | Leptin Analog [EPC] | 2 | 0.0016 |
| 8 | Acetylcholine Release Inhibitor [EPC] | 151 | 0.0015 |
| 9 | Cytolytic Agent [EPC] | 3 | 0.0013 |